CClinicalTrials.gg
RecruitingNCT06512675Updated Oct 1, 2026

Effects of an Exercise Program on Reaction Time and Mouse Accuracy in Recreational Video Game Players

An interventional study of Resistance combined with cardiovascular training in Quality of Life, sponsored by University of Miami. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-01.

Sponsored by University of Miami · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Oct 2025; still recruiting 11 months later.
Updated Oct 1, 2026Primary completion movedStudy completion movedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

This study is intended to evaluate the effects of an exercise program on the change of electronic sports (esports) athletes' reaction time and mouse click accuracy. The benefits of participation are directly related to exercise, and include improved thinking, performance, sleep, and quality of life.

02

Conditions studied

  • Quality of Life

Browse trials for

Keywords

  • Exercise
03

In context

Motor Activity

2,426 studies on the registry are indexed under Motor Activity; 1,161 are open to participants now.

This study's planned enrollment of 15 is below the median of 60 across 2,118 interventional studies indexed under Motor Activity.

Browse Motor Activity studies →

Lead sponsor

University of Miami is the lead sponsor of 820 studies on the registry; 161 are open to participants now.

Of its 111 completed or terminated interventional studies of FDA-regulated products, 93 (84%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Minimum age is 18, and there is no maximum.
  2. Must play video games for at least an average of one hour per week
  3. University of Miami College student or University of Miami Miller School of Medicine student

Exclusion criteria

Exclusion criteria:

  1. Individuals who are not able to participate in a full body exercise program, whether due to injury or an underlying medical condition
  2. Individuals who cannot comprehend basic instruction on exercise whether due to a cognitive impairment or language barrier (ie: non English speaker).
  3. Conditions that require further medical workup including History or symptoms of cardiac disease, family history of sudden cardiac death, sickle cell disease, history of exercise-related syncope, uncontrolled exercise-associated asthma, acute fractures, active infectious rash, symptoms of relative energy deficiency syndrome, eating disorders.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    Resistance combined with cardiovascular training group

    Participants in this group will receive the resistance combined with cardiovascular training intervention for up to 6 weeks

    Other: Resistance combined with cardiovascular training

Interventions

  • OtherResistance combined with cardiovascular training

    Participants will undergo a 6-week exercise program designed under the supervision of a board certified sports medicine physician. The exercise program will consist of a 3 day per week schedule: Monday will be lower body resistance training, Wednesday will be aerobic exercise, and Friday will be upper body resistance training. Each session will be approximately up to 1 hour.

06

What researchers measure

Primary outcomes

  1. Change in participants' physical reaction time

    Participants' reaction time will be measured in milliseconds using open-source software "Open-source open-access reaction time test"

    Time frame: Baseline and up to 6 weeks after starting the program

  2. Change in percentage of participants' mouse click accuracy

    Participants' mouse click accuracy will be measured as a percentage using a web-based program, "Mouse Accuracy"

    Time frame: Baseline and up to 6 weeks after starting the program

Secondary outcomes

  1. Change in participants' number of target efficiency

    Change in participants' number of target efficiency will be calculated as number of hits divided by possible targets using "Mouse Accuracy"

    Time frame: Baseline and up to 6 weeks after starting the program

  2. Change in participants' clicks per second

    Change in participants' clicks per second will be measured by counting actual mouse clicks per second using "Mouse Accuracy"

    Time frame: Baseline and up to 6 weeks after starting the program

07

Study locations

1 of 1 sites recruiting
  • University of Miami
    Miami, Florida 33146, United States
    • Timothy Tiu, MD · Contact · ttiu@miami.edu · 305.243.3140
    • Timothy Tiu, MD · Principal investigator
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Primary completion
Jul 1, 2026→May 1, 2027
Oct 1, 2026
Study completion
Jul 1, 2026→May 1, 2027
Oct 1, 2026
Show all 1 update
  1. Oct 1, 2026
    Primary completion Jul 1, 2026→May 1, 2027
    Study completion Jul 1, 2026→May 1, 2027

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06512675
Lead sponsor
University of Miami
Responsible party
Timothy Tiu (Associate Professor, University of Miami) — Principal investigator
First posted
Jul 22, 2024
Start date
Oct 17, 2025
Primary completion
May 1, 2027 (estimated)
Completion
May 1, 2027 (estimated)
Last update
Oct 1, 2026

Study contacts

Timothy Tiu, MD
Contact
ttiu@miami.edu
305.243.3140
Timothy Tiu, MD
principal investigator · University of Miami

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion